MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-10-0008243
Harasha Pharma Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹17.49 Cr
▼ 35% YoY
Net profit · FY 2025
₹41.47 Lakh
Net margin 2.4%
EBITDA · FY 2025
₹2.18 Cr
EBITDA margin 12.4%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.46 Cr
Issued & subscribed
Open charges
₹4.62 Cr
Satisfied ₹3.56 Cr
Company age
29 yrs
Est. 1997
Directors on board
2
As per MCA filings
About Harasha Pharma Private Limited
Data last updated:
Harasha Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 02 January 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U02423DL1997PTC084196. Its GSTIN is 07AAACH5293B1ZU (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.46 Cr. It is led by directors Monika Singla and Riman Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 351 Plot No. 351, Bharthal Village Road, New Delhi, Delhi, India – 110077.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.49 Cr, a decline of 35% compared to the previous year. For the same year it recorded a net profit of ₹41.47 Lakh (net margin 2.4%) and EBITDA of ₹2.18 Cr (EBITDA margin 12.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 34% over five years.
As per MCA filings, the company has open charges of ₹4.62 Cr and satisfied charges of ₹3.56 Cr on record. Court records list 15 cases involving the company, including 2 filed by the company and 13 filed against it; 6 cases are pending. The company has 6 deals on record (4 rights issues, 2 funding rounds), with disclosed funding of ₹15.1 Lakh; the latest was in September 2022. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 1 smaller; the largest is Aarsh Remedies Private Limited with revenue of ₹17.64 Cr.
Harasha Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0008243). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website harasha.in.
Company details
CIN U02423DL1997PTC084196
Registration Number 084196
Incorporation Date 02 January 1997
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-10-0008243
Key People
Monika Singla Director Riman Gupta Director Recognitions & Rankings of Harasha Pharma
Contact details
Harasha Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is harasha.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 351 Plot No. 351, Bharthal Village Road, New Delhi, Delhi, India – 110077
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Harasha Pharma Private Limited, buy the company report.
Comprehensive company report
Harasha Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Harasha Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Harasha Pharma Private Limited, buy the company report.
Financials of Harasha Pharma Private Limited
FY 2024 filings availableHarasha Pharma Private Limited reported revenue of ₹17.49 Cr (down 35% YoY) for FY 2025.
Revenue · FY 2025
₹17.49 Cr ▼ 35%
Net profit · FY 2025
₹41.47 Lakh margin 2.4%
EBITDA · FY 2025
₹2.18 Cr margin 12.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 35%
3 years · compounded
▼ 3%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 71%
3 years · compounded
▲ 7%
5 years · compounded
▲ 33%
Revenue fell 35% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 34%. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.4% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Harasha Pharma Private Limited, buy the company report.
Board of directors of Harasha Pharma Private Limited
Harasha Pharma has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monika Singla | Director | 10 May 2012 | 14 Years 5 Months | Current |
| Riman Gupta | Director | 13 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
Harasha Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aarsh Remedies Private Limited | ₹17.64 Cr (FY 2025) | 34.0% | Ahmedabad, Gujarat, India | |||
| Nulife Pharmaceuticals Private Limited | ₹17.55 Cr (FY 2024) | 6.0% | Mumbai, Maharashtra, India | |||
| Harasha Pharma Private Limitedthis company | ₹17.49 Cr (FY 2025) | ₹41.47 Lakh | 2.4% | -35.0% | New Delhi, Delhi, India | |
| Corpus Lifescience Private Limited | ₹17.4 Cr (FY 2025) | 19.0% | Serampore, West Bengal, India |
To see the full peer comparison of Harasha Pharma Private Limited, buy the company report.
Auditor
Harasha Pharma Private Limited is audited by RAJ ANIRUDH AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJ ANIRUDH AND ASSOCIATES | FY 2023 | 020497N |
Shareholding
The shareholding of Harasha Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Harasha Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.62 Cr
Satisfied charges
₹3.56 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Sep 2024 | 100990692 | Others | ₹1.32 Cr | Open | |
| 30 Apr 2008 | 10103499 | Canara Bank | ₹3.3 Cr | Open | |
| 09 Nov 2021 | 100506856 | Canara Bank | ₹8 Lakh | Satisfied | |
| 19 Jun 2021 | 100455981 | Yes Bank Limited | ₹3 Cr | Satisfied | |
| 02 Jun 2021 | 100454143 | Canara Bank | ₹21.9 Lakh | Satisfied |
To see the full charge records of Harasha Pharma Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Harasha Pharma Private Limited has 6 deals on record (4 rights issues, 2 funding rounds), with disclosed funding of ₹15.1 Lakh; the latest was in September 2022.
Total deals
6
Rights issues
4
Funding rounds
2
Disclosed funding
₹15.1 Lakh
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2022 | Rights issue | ₹50 Lakh | Investors: 2 individuals |
| Nov 2020 | Rights issue | ₹92.2 Lakh | Investors: 3 individuals |
| Mar 2020 | Rights issue | ₹28 Lakh | Investors: 2 individuals |
| Mar 2017 | Rights issue | ₹19.9 Lakh | Investors: 2 individuals |
| Jan 2013 | Funding round | ₹8.1 Lakh | Investors: 2 individuals |
To see the full deal history of Harasha Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Harasha Pharma Private Limited has 15 court cases on record: 2 filed by Harasha Pharma, 13 filed against it. 6 cases are pending and 9 are disposed.
Total cases
15
Filed by the company
2
Filed against the company
13
Pending
6
Disposed
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 11 | 6 |
| High courts | 1 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Moneywise Financial Services Pvt Ltd | Pending |
| District court, South, Delhi | Cheque dishonour complaint | Filed against the company by Ugro Capital Limited | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed against the company by Hero Fincorp Ltd | Pending |
| District court, South, Delhi | Cheque dishonour complaint | Filed against the company by Godrej Finance Limited | Disposed |
| High Court of Delhi | Commercial suit | Filed against the company by Bhargava Phytolab Private Limited | Disposed |
To see the full case history of Harasha Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Harasha Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Harasha Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACH5293B1ZU | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Harasha Pharma Private Limited, buy the company report.
Recent activity
Harasha Pharma Private Limited has 10 board changes on record since 2011: 2 appointments and 8 cessations. The latest: Tanney Manav Singla ceased to be Director on 23 Aug 2025.
Ceased
Tanney Manav Singla ceased to be Director.
Appointed
Riman Gupta was appointed as Director.
Ceased
Manav Harsh Singla ceased to be Director.
AGM
Harasha Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 19 Jun 2021 via Charge ID 100455981 with Yes Bank Limited was fully satisfied on 25 Sep 2024.
Charges
A charge with Others amounted to Rs. 1.32 Cr with Charge ID 100990692 was registered on 21 Sep 2024.
Charges
A charge with Canara Bank of Rs. 3.30 Cr registered on 30 Apr 2008 with Charge ID 10103499 was modified on 12 Apr 2024.
Filing
Harasha Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge registered on 02 Jun 2021 via Charge ID 100454143 with Canara Bank was fully satisfied on 12 Jan 2023.
Charges
A charge registered on 09 Nov 2021 via Charge ID 100506856 with Canara Bank was fully satisfied on 16 Dec 2022.
Charges
A charge registered on 16 Jul 2020 via Charge ID 100365793 with Canara Bank was fully satisfied on 16 Dec 2022.
Charges
A charge with Canara Bank amounted to Rs. 0.08 Cr with Charge ID 100506856 was registered on 09 Nov 2021.
14 earlier events are in the company report.
Frequently asked questions
Harasha Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 02 January 1997 (29+ years old) and is registered under CIN U02423DL1997PTC084196.
Harasha Pharma has 2 current directors:
- Monika Singla - Director
- Riman Gupta - Director
The latest financial statements of Harasha Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Harasha Pharma is 07AAACH5293B1ZU, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Harasha Pharma is U02423DL1997PTC084196. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Harasha Pharma has 15 court cases on record: 2 filed by the company and 13 filed against it. 6 are pending. Most are in the district courts.
Harasha Pharma was incorporated on 02 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.
Harasha Pharma has 6 deals on record (4 rights issues, 2 funding rounds), with disclosed funding of ₹15.1 Lakh; the latest was in September 2022.
The peers of Harasha Pharma by revenue are Aarsh Remedies Private Limited, Nulife Pharmaceuticals Private Limited, Corpus Lifescience Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Tanney Manav Singla ceased to be Director on 23 Aug 2025. Riman Gupta was appointed as Director on 13 Aug 2025. Manav Harsh Singla ceased to be Director on 28 Feb 2025. Harasha Pharma has 10 board changes on record in total.
Yes, Harasha Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-10-0008243).